Literature DB >> 22451663

Plasminogen is a complement inhibitor.

Diana Barthel1, Susann Schindler, Peter F Zipfel.   

Abstract

Plasminogen is a 92-kDa single chain glycoprotein that circulates in plasma as a zymogen and when converted to proteolytically active plasmin dissolves preformed fibrin clots and extracellular matrix components. Here, we characterize the role of plasmin(ogen) in the complement cascade. Plasminogen binds the central complement protein C3, the C3 cleavage products C3b and C3d, and C5. Plasminogen binds to C3, C3b, C3d, and C5 via lysine residues, and the interaction is ionic strength-dependent. Plasminogen and Factor H bind C3b; however, the two proteins bind to different sites and do not compete for binding. Plasminogen affects complement action in multiple ways. Plasminogen enhanced Factor I-mediated C3b degradation in the presence of the cofactor Factor H. Plasminogen when activated to plasmin inhibited complement as demonstrated by hemolytic assays using either rabbit or sheep erythrocytes. Similarly, plasmin either in the fluid phase or attached to surfaces inhibited complement that was activated via the alternative and classical pathways and cleaved C3b to fragments of 68, 40, 30, and 17 kDa. The C3b fragments generated by plasmin differ in size from those generated by the complement protease Factor I, suggesting that plasmin-mediated C3b cleavage fragments lack effector function. Plasmin also cleaved C5 to products of 65, 50, 30, and 25 kDa. Thus, plasmin(ogen) regulates both complement and coagulation, the two central cascade systems of a vertebrate organism. This complement-inhibitory activity of plasmin provides a new explanation why pathogenic microbes utilize plasmin(ogen) for immune evasion and tissue penetration.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451663      PMCID: PMC3365705          DOI: 10.1074/jbc.M111.323287

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

1.  Complement and coagulation: causative considerations in contrast catastrophies.

Authors:  E C Lasser; J Slivka; J H Lang; W P Kolb; S G Lyon; A E Hamblin; G Nazareno
Journal:  AJR Am J Roentgenol       Date:  1979-02       Impact factor: 3.959

2.  An epitope of elongation factor Tu is widely distributed within the bacterial and archaeal domains.

Authors:  S Weber; F Lottspeich; J Köhl
Journal:  J Bacteriol       Date:  1995-01       Impact factor: 3.490

3.  The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins.

Authors:  C Skerka; J Hellwage; W Weber; A Tilkorn; F Buck; T Marti; E Kampen; U Beisiegel; P F Zipfel
Journal:  J Biol Chem       Date:  1997-02-28       Impact factor: 5.157

4.  Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system.

Authors:  T E Petersen; M R Martzen; A Ichinose; E W Davie
Journal:  J Biol Chem       Date:  1990-04-15       Impact factor: 5.157

5.  Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

Authors:  I Gigli; T Fujita; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

6.  PAM, a novel plasminogen-binding protein from Streptococcus pyogenes.

Authors:  A Berge; U Sjöbring
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

Review 7.  Plasminogen: a brief introduction into its biochemistry and function.

Authors:  C Miyashita; E Wenzel; M Heiden
Journal:  Haemostasis       Date:  1988

8.  Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis.

Authors:  T Seya; S Nagasawa; M Matsukura; H Hasegawa; J P Atkinson
Journal:  Complement       Date:  1985

9.  Amino-acid sequence of activation cleavage site in plasminogen: homology with "pro" part of prothrombin.

Authors:  L Sottrup-Jensen; M Zajdel; H Claeys; T E Petersen; S Magnusson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-07       Impact factor: 11.205

10.  Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.

Authors:  L A Moroz; N J Gilmore
Journal:  Blood       Date:  1976-10       Impact factor: 22.113

View more
  68 in total

1.  Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury.

Authors:  Jennifer Laskowski; Brandon Renner; Moglie Le Quintrec; Sarah Panzer; Jonathan P Hannan; Danica Ljubanovic; Marieta M Ruseva; Dorin-Bogdan Borza; Alexandra H Antonioli; Matthew C Pickering; V Michael Holers; Joshua M Thurman
Journal:  Kidney Int       Date:  2016-05-07       Impact factor: 10.612

2.  Mutation Drivers of Immunological Responses to Cancer.

Authors:  Eduard Porta-Pardo; Adam Godzik
Journal:  Cancer Immunol Res       Date:  2016-07-11       Impact factor: 11.151

3.  Streptococcus pneumoniae phosphoglycerate kinase is a novel complement inhibitor affecting the membrane attack complex formation.

Authors:  Anna M Blom; Simone Bergmann; Marcus Fulde; Kristian Riesbeck; Vaibhav Agarwal
Journal:  J Biol Chem       Date:  2014-10-03       Impact factor: 5.157

4.  Plasmin-mediated fibrinolysis enables macrophage migration in a murine model of inflammation.

Authors:  Lakmali Munasinghage Silva; Andrew Gary Lum; Collin Tran; Molly W Shaw; Zhen Gao; Matthew J Flick; Niki M Moutsopoulos; Thomas H Bugge; Eric S Mullins
Journal:  Blood       Date:  2019-05-17       Impact factor: 22.113

5.  Brief report: carboxypeptidase B serves as a protective mediator in osteoarthritis.

Authors:  Christin M Lepus; Jason J Song; Qian Wang; Catriona A Wagner; Tamsin M Lindstrom; Constance R Chu; Jeremy Sokolove; Lawrence L Leung; William H Robinson
Journal:  Arthritis Rheumatol       Date:  2014-01       Impact factor: 10.995

6.  Plasminogen Deficiency Delays the Onset and Protects from Demyelination and Paralysis in Autoimmune Neuroinflammatory Disease.

Authors:  Maureen A Shaw; Zhen Gao; Kathryn E McElhinney; Sherry Thornton; Matthew J Flick; Adam Lane; Jay L Degen; Jae Kyu Ryu; Katerina Akassoglou; Eric S Mullins
Journal:  J Neurosci       Date:  2017-03-08       Impact factor: 6.167

7.  Analysis of the complement sensitivity of oral treponemes and the potential influence of FH binding, FH cleavage and dentilisin activity on the pathogenesis of periodontal disease.

Authors:  D P Miller; J V McDowell; J K Bell; M P Goetting-Minesky; J C Fenno; R T Marconi
Journal:  Mol Oral Microbiol       Date:  2014-06-03       Impact factor: 3.563

8.  No association between dysplasminogenemia with p.Ala620Thr mutation and atypical hemolytic uremic syndrome.

Authors:  Toshiyuki Miyata; Yumiko Uchida; Yoko Yoshida; Hideki Kato; Masanori Matsumoto; Koichi Kokame; Yoshihiro Fujimura; Masaomi Nangaku
Journal:  Int J Hematol       Date:  2016-05-18       Impact factor: 2.490

9.  Versatile roles of CspA orthologs in complement inactivation of serum-resistant Lyme disease spirochetes.

Authors:  Claudia Hammerschmidt; Arno Koenigs; Corinna Siegel; Teresia Hallström; Christine Skerka; Reinhard Wallich; Peter F Zipfel; Peter Kraiczy
Journal:  Infect Immun       Date:  2013-11-04       Impact factor: 3.441

Review 10.  Extracellular molecules in hematopoietic stem cell mobilisation.

Authors:  Linda Bendall
Journal:  Int J Hematol       Date:  2016-11-08       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.